Evolent Health News

JMP Securities Maintains Evolent Health(EVH.US) With Buy Rating, Raises Target Price to $43

Moomoo NewsSep 6 14:32 ET

Evolent Health Buy Rating Affirmed With Increased Price Target Amid Growth Prospects and M&A Speculation

TipRanksSep 6 13:58 ET

Evolent Health Price Target Maintained With a $33.00/Share by Truist Securities

Dow JonesAug 27 10:27 ET

Truist Financial Maintains Evolent Health(EVH.US) With Buy Rating

Moomoo NewsAug 27 07:35 ET

Evolent Health Analyst Ratings

BenzingaAug 26 09:04 ET

RBC Capital Maintains Evolent Health(EVH.US) With Buy Rating, Maintains Target Price $42

Moomoo NewsAug 26 07:31 ET

Truist Financial Maintains Evolent Health(EVH.US) With Buy Rating

Moomoo NewsAug 26 07:31 ET

Evolent Health (EVH) Gets a Buy From RBC Capital

TipRanksAug 26 06:48 ET

Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY) and Evolent Health (EVH)

TipRanksAug 26 06:47 ET

A Quick Look at Today's Ratings for Evolent Health(EVH.US), With a Forecast Between $38 to $45

Moomoo NewsAug 23 09:02 ET

Evolent Health Analyst Ratings

BenzingaAug 19 08:55 ET

J.P. Morgan Maintains Evolent Health(EVH.US) With Buy Rating, Announces Target Price $45

Moomoo NewsAug 19 08:31 ET

CCORF Maintains Evolent Health(EVH.US) With Buy Rating, Maintains Target Price $33

Moomoo NewsAug 14 07:36 ET

Evolent Health Poised for Growth: Strategic Acquisition and Strong Organic Prospects Fuel Buy Rating

TipRanksAug 14 07:25 ET

RBC Capital Keeps Their Buy Rating on Evolent Health (EVH)

TipRanksAug 9 08:04 ET

Evolent Health (EVH): A Buy Rating With Robust Growth and Strategic Initiatives

TipRanksAug 9 07:59 ET

Evolent Health Price Target Cut to $31.00/Share From $34.00 by JMP Securities

Dow JonesAug 9 07:14 ET

Evolent Health Analyst Ratings

BenzingaAug 9 05:50 ET

Evolvent Health's Strong Q2 Performance and Promising Outlook Bolster Buy Rating

TipRanksAug 9 00:55 ET

J.P. Morgan Maintains Evolent Health(EVH.US) With Buy Rating

Moomoo NewsAug 1 09:31 ET